The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCES INC | Common | 00032Q104 | 40,262 | 2,849,402 | SH | SOLE | 2,849,402 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | Common | 02043Q107 | 221,177 | 1,105,000 | SH | SOLE | 1,105,000 | 0 | 0 | ||
AMARIN CORP PLC | Sponsored ADR | 023111206 | 6,540 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | Common | 03152W109 | 279,792 | 26,800,000 | SH | SOLE | 26,800,000 | 0 | 0 | ||
AMYLYX PHARMACEUTICALS INC | Common | 03237H101 | 18,298 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | Common | 03753U106 | 691,538 | 10,125,000 | SH | SOLE | 10,125,000 | 0 | 0 | ||
ARGENX SE | Sponsored ADR | 04016X101 | 446,804 | 1,265,555 | SH | SOLE | 1,265,555 | 0 | 0 | ||
ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 294,291 | 2,850,000 | SH | SOLE | 2,850,000 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | Common | 05370A108 | 23,679 | 1,450,000 | SH | SOLE | 1,450,000 | 0 | 0 | ||
BIOATLA INC | Common | 09077B104 | 4,428 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | Common | 09058V103 | 114,030 | 9,050,000 | SH | SOLE | 9,050,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 301,404 | 3,555,555 | SH | SOLE | 3,555,555 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | Common | 23257D103 | 36,050 | 10,300,000 | SH | SOLE | 10,300,000 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | Common | 25056L103 | 37,156 | 2,222,222 | SH | SOLE | 2,222,222 | 0 | 0 | ||
DICE THERAPEUTICS INC | Common | 23345J104 | 21,801 | 1,075,000 | SH | SOLE | 1,075,000 | 0 | 0 | ||
FENNEC PHARMACEUTICALS INC | Common | 31447P100 | 9,720 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PLC | Common | G46188101 | 317,186 | 5,125,000 | SH | SOLE | 5,125,000 | 0 | 0 | ||
IO BIOTECH INC | Common | 449778109 | 5,571 | 2,055,883 | SH | SOLE | 2,055,883 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 86,412 | 9,020,000 | SH | SOLE | 9,020,000 | 0 | 0 | ||
IVERIC BIO INC | Common | 46583P102 | 105,846 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | ||
KRYSTAL BIOTECH INC | Common | 501147102 | 88,868 | 1,275,000 | SH | SOLE | 1,275,000 | 0 | 0 | ||
KURA ONCOLOGY INC | Common | 50127T109 | 48,152 | 3,525,000 | SH | SOLE | 3,525,000 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | Common | 501575104 | 47,224 | 2,169,230 | SH | SOLE | 2,169,230 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 99,760 | 1,535,000 | SH | SOLE | 1,535,000 | 0 | 0 | ||
MANNKIND CORP | Common | 56400P706 | 28,119 | 9,100,000 | SH | SOLE | 9,100,000 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | Common | 56854Q200 | 20,948 | 3,150,000 | SH | SOLE | 3,150,000 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | Common | 59045L106 | 51,038 | 7,550,000 | SH | SOLE | 7,550,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | Common | 60468T105 | 387,651 | 5,550,555 | SH | SOLE | 5,550,555 | 0 | 0 | ||
MONTE ROSA THERAPEUTICS INC | Common | 61225M102 | 27,478 | 3,363,333 | SH | SOLE | 3,363,333 | 0 | 0 | ||
NUVALENT INC | Common | 670703107 | 20,402 | 1,049,471 | SH | SOLE | 1,049,471 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | Common | 69353Y103 | 36,414 | 3,060,000 | SH | SOLE | 3,060,000 | 0 | 0 | ||
RELAY THERAPEUTICS INC | Common | 75943R102 | 8,948 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | Common | 803607100 | 350,965 | 3,175,000 | SH | SOLE | 3,175,000 | 0 | 0 | ||
SEAGEN INC | Common | 81181C104 | 255,188 | 1,865,000 | SH | SOLE | 1,865,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | Common | 87164F105 | 53,400 | 2,222,222 | SH | SOLE | 2,222,222 | 0 | 0 | ||
TANGO THERAPEUTICS INC | Common | 87583X109 | 5,611 | 1,550,000 | SH | SOLE | 1,550,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL INC | Common | 90400D108 | 31,058 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | Common | 91307C102 | 612,751 | 2,926,500 | SH | SOLE | 2,926,500 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | Common | 98420N105 | 176,890 | 4,900,000 | SH | SOLE | 4,900,000 | 0 | 0 |